img

Global and United States Monkeypox Treatment Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global and United States Monkeypox Treatment Market Report & Forecast 2024-2034

Monkeypox (mpox) is a viral infection that spreads from animals to humans, hence it is called a zoonotic infection. The recent outbreak of mpox on May 6, 2022. The human mpox virus was initially identified in 1970 in the Democratic Republic of Congo. The source of the virus is unknown; however, the first six monkeypox cases were found in the UK. Fever, swelling in the lymph nodes, rashes on the skin, chills, muscle fatigue, headache, backache, and respiratory symptoms such as sore throat, cough, and congestion are the common symptoms of monkeypox infection. The virus is transmitted sexually or through touch. The disease has claimed the lives of some people. People with weak immunity, breastfeeding mothers, women during pregnancy, children below the age of 10 years, and people having prolonged exposure to the infected animal are susceptible to the viral infection.
Market Analysis and InsightsGlobal and United States Monkeypox Treatment Market
This report focuses on global and United States Monkeypox Treatment market, also covers the segmentation data of other regions in regional level and county level.
The global Monkeypox Treatment revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Monkeypox Treatment revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Monkeypox Treatment include Bavarian Nordic, Chimerix, Inc., CIDIC Company Limited, Emcure Pharmaceuticals, Emergent, Gilead Sciences Inc., Hetero Drugs Limited, Jinan Jinda Pharmaceutical Chemistry Co. Ltd. and Mylan N.V., etc. The global five biggest players hold a share of % in 2022.
Global Monkeypox Treatment Scope and Market Size
Monkeypox Treatment market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Monkeypox Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Monkeypox Treatment market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


Bavarian Nordic
Chimerix, Inc.
CIDIC Company Limited
Emcure Pharmaceuticals
Emergent
Gilead Sciences Inc.
Hetero Drugs Limited
Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
Mylan N.V.
Olon S.p.A.
Piramal Pharma Solutions
SIGA Technologies Inc.
Sonofi SA
Teva Pharmaceutical Industries Limited
Segment by Type
Oral
Injectable

Segment by Application


Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Monkeypox Treatment definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Monkeypox Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Monkeypox Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Monkeypox Treatment revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Monkeypox Treatment Product Introduction
1.2 Global Monkeypox Treatment Outlook 2018 VS 2022 VS 2033
1.2.1 Global Monkeypox Treatment Market Size for the Year 2018-2033
1.2.2 United States Monkeypox Treatment Market Size for the Year 2018-2033
1.3 Monkeypox Treatment Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of United States Monkeypox Treatment in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of Monkeypox Treatment Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.4 Monkeypox Treatment Market Dynamics
1.4.1 Monkeypox Treatment Industry Trends
1.4.2 Monkeypox Treatment Market Drivers
1.4.3 Monkeypox Treatment Market Challenges
1.4.4 Monkeypox Treatment Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Monkeypox Treatment by Type
2.1 Monkeypox Treatment Market Segment by Type
2.1.1 Oral
2.1.2 Injectable
2.2 Global Monkeypox Treatment Market Size by Type (2018, 2022 & 2033)
2.3 Global Monkeypox Treatment Market Size by Type (2018-2033)
2.4 United States Monkeypox Treatment Market Size by Type (2018, 2022 & 2033)
2.5 United States Monkeypox Treatment Market Size by Type (2018-2033)
3 Monkeypox Treatment by Application
3.1 Monkeypox Treatment Market Segment by Application
3.1.1 Hospital Pharmacy
3.1.2 Online Pharmacy
3.1.3 Retail Pharmacy
3.2 Global Monkeypox Treatment Market Size by Application (2018, 2022 & 2033)
3.3 Global Monkeypox Treatment Market Size by Application (2018-2033)
3.4 United States Monkeypox Treatment Market Size by Application (2018, 2022 & 2033)
3.5 United States Monkeypox Treatment Market Size by Application (2018-2033)
4 Global Monkeypox Treatment Competitor Landscape by Company
4.1 Global Monkeypox Treatment Market Size by Company
4.1.1 Global Key Companies of Monkeypox Treatment, Ranked by Revenue (2022)
4.1.2 Global Monkeypox Treatment Revenue by Player (2018-2023)
4.2 Global Monkeypox Treatment Concentration Ratio (CR)
4.2.1 Monkeypox Treatment Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Monkeypox Treatment in 2022
4.2.3 Global Monkeypox Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Monkeypox Treatment Head office and Area Served
4.4 Global Key Players of Monkeypox Treatment, Product and Application
4.5 Global Key Players of Monkeypox Treatment, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Monkeypox Treatment Market Size by Company
4.7.1 Key Players of Monkeypox Treatment in United States, Ranked by Revenue (2022)
4.7.2 United States Monkeypox Treatment Revenue by Players (2021, 2022 & 2023)
5 Global Monkeypox Treatment Market Size by Region
5.1 Global Monkeypox Treatment Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Monkeypox Treatment Market Size by Region (2018-2033)
5.2.1 Global Monkeypox Treatment Market Size by Region: 2018-2023
5.2.2 Global Monkeypox Treatment Market Size by Region (2024-2033)
6 Americas
6.1 Americas Monkeypox Treatment Market Size YoY Growth 2018-2033
6.2 Americas Monkeypox Treatment Market Size by Type
6.2.1 Americas Monkeypox Treatment Market Size by Type (2018-2023)
6.2.2 Americas Monkeypox Treatment Market Size by Type (2024-2033)
6.2.3 Americas Monkeypox Treatment Market Share by Type (2018-2033)
6.3 Americas Monkeypox Treatment Market Size by Application
6.3.1 Americas Monkeypox Treatment Market Size by Application (2018-2023)
6.3.2 Americas Monkeypox Treatment Market Size by Application (2024-2033)
6.3.3 Americas Monkeypox Treatment Market Share by Application (2018-2033)
6.4 Americas Monkeypox Treatment Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Monkeypox Treatment Market Size YoY Growth 2018-2033
7.2 EMEA Monkeypox Treatment Market Size by Type
7.2.1 EMEA Monkeypox Treatment Market Size by Type (2018-2023)
7.2.2 EMEA Monkeypox Treatment Market Size by Type (2024-2033)
7.2.3 EMEA Monkeypox Treatment Market Share by Type (2018-2033)
7.3 EMEA Monkeypox Treatment Market Size by Application
7.3.1 EMEA Monkeypox Treatment Market Size by Application (2018-2023)
7.3.2 EMEA Monkeypox Treatment Market Size by Application (2024-2033)
7.3.3 EMEA Monkeypox Treatment Market Share by Application (2018-2033)
7.4 EMEA Monkeypox Treatment Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Monkeypox Treatment Market Size YoY Growth 2018-2033
8.2 China Monkeypox Treatment Market Size by Type
8.2.1 China Monkeypox Treatment Market Size by Type (2018-2023)
8.2.2 China Monkeypox Treatment Market Size by Type (2024-2033)
8.2.3 China Monkeypox Treatment Market Share by Type (2018-2033)
8.3 China Monkeypox Treatment Market Size by Application
8.3.1 China Monkeypox Treatment Market Size by Application (2018-2023)
8.3.2 China Monkeypox Treatment Market Size by Application (2024-2033)
8.3.3 China Monkeypox Treatment Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Monkeypox Treatment Market Size YoY Growth 2018-2033
9.2 APAC Monkeypox Treatment Market Size by Type
9.2.1 APAC Monkeypox Treatment Market Size by Type (2018-2023)
9.2.2 APAC Monkeypox Treatment Market Size by Type (2024-2033)
9.2.3 APAC Monkeypox Treatment Market Share by Type (2018-2033)
9.3 APAC Monkeypox Treatment Market Size by Application
9.3.1 APAC Monkeypox Treatment Market Size by Application (2018-2023)
9.3.2 APAC Monkeypox Treatment Market Size by Application (2024-2033)
9.3.3 APAC Monkeypox Treatment Market Share by Application (2018-2033)
9.4 APAC Monkeypox Treatment Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Bavarian Nordic
10.1.1 Bavarian Nordic Company Details
10.1.2 Bavarian Nordic Business Overview
10.1.3 Bavarian Nordic Monkeypox Treatment Introduction
10.1.4 Bavarian Nordic Revenue in Monkeypox Treatment Business (2018-2023)
10.1.5 Bavarian Nordic Recent Development
10.2 Chimerix, Inc.
10.2.1 Chimerix, Inc. Company Details
10.2.2 Chimerix, Inc. Business Overview
10.2.3 Chimerix, Inc. Monkeypox Treatment Introduction
10.2.4 Chimerix, Inc. Revenue in Monkeypox Treatment Business (2018-2023)
10.2.5 Chimerix, Inc. Recent Development
10.3 CIDIC Company Limited
10.3.1 CIDIC Company Limited Company Details
10.3.2 CIDIC Company Limited Business Overview
10.3.3 CIDIC Company Limited Monkeypox Treatment Introduction
10.3.4 CIDIC Company Limited Revenue in Monkeypox Treatment Business (2018-2023)
10.3.5 CIDIC Company Limited Recent Development
10.4 Emcure Pharmaceuticals
10.4.1 Emcure Pharmaceuticals Company Details
10.4.2 Emcure Pharmaceuticals Business Overview
10.4.3 Emcure Pharmaceuticals Monkeypox Treatment Introduction
10.4.4 Emcure Pharmaceuticals Revenue in Monkeypox Treatment Business (2018-2023)
10.4.5 Emcure Pharmaceuticals Recent Development
10.5 Emergent
10.5.1 Emergent Company Details
10.5.2 Emergent Business Overview
10.5.3 Emergent Monkeypox Treatment Introduction
10.5.4 Emergent Revenue in Monkeypox Treatment Business (2018-2023)
10.5.5 Emergent Recent Development
10.6 Gilead Sciences Inc.
10.6.1 Gilead Sciences Inc. Company Details
10.6.2 Gilead Sciences Inc. Business Overview
10.6.3 Gilead Sciences Inc. Monkeypox Treatment Introduction
10.6.4 Gilead Sciences Inc. Revenue in Monkeypox Treatment Business (2018-2023)
10.6.5 Gilead Sciences Inc. Recent Development
10.7 Hetero Drugs Limited
10.7.1 Hetero Drugs Limited Company Details
10.7.2 Hetero Drugs Limited Business Overview
10.7.3 Hetero Drugs Limited Monkeypox Treatment Introduction
10.7.4 Hetero Drugs Limited Revenue in Monkeypox Treatment Business (2018-2023)
10.7.5 Hetero Drugs Limited Recent Development
10.8 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
10.8.1 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Company Details
10.8.2 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Business Overview
10.8.3 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Introduction
10.8.4 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue in Monkeypox Treatment Business (2018-2023)
10.8.5 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Recent Development
10.9 Mylan N.V.
10.9.1 Mylan N.V. Company Details
10.9.2 Mylan N.V. Business Overview
10.9.3 Mylan N.V. Monkeypox Treatment Introduction
10.9.4 Mylan N.V. Revenue in Monkeypox Treatment Business (2018-2023)
10.9.5 Mylan N.V. Recent Development
10.10 Olon S.p.A.
10.10.1 Olon S.p.A. Company Details
10.10.2 Olon S.p.A. Business Overview
10.10.3 Olon S.p.A. Monkeypox Treatment Introduction
10.10.4 Olon S.p.A. Revenue in Monkeypox Treatment Business (2018-2023)
10.10.5 Olon S.p.A. Recent Development
10.11 Piramal Pharma Solutions
10.11.1 Piramal Pharma Solutions Company Details
10.11.2 Piramal Pharma Solutions Business Overview
10.11.3 Piramal Pharma Solutions Monkeypox Treatment Introduction
10.11.4 Piramal Pharma Solutions Revenue in Monkeypox Treatment Business (2018-2023)
10.11.5 Piramal Pharma Solutions Recent Development
10.12 SIGA Technologies Inc.
10.12.1 SIGA Technologies Inc. Company Details
10.12.2 SIGA Technologies Inc. Business Overview
10.12.3 SIGA Technologies Inc. Monkeypox Treatment Introduction
10.12.4 SIGA Technologies Inc. Revenue in Monkeypox Treatment Business (2018-2023)
10.12.5 SIGA Technologies Inc. Recent Development
10.13 Sonofi SA
10.13.1 Sonofi SA Company Details
10.13.2 Sonofi SA Business Overview
10.13.3 Sonofi SA Monkeypox Treatment Introduction
10.13.4 Sonofi SA Revenue in Monkeypox Treatment Business (2018-2023)
10.13.5 Sonofi SA Recent Development
10.14 Teva Pharmaceutical Industries Limited
10.14.1 Teva Pharmaceutical Industries Limited Company Details
10.14.2 Teva Pharmaceutical Industries Limited Business Overview
10.14.3 Teva Pharmaceutical Industries Limited Monkeypox Treatment Introduction
10.14.4 Teva Pharmaceutical Industries Limited Revenue in Monkeypox Treatment Business (2018-2023)
10.14.5 Teva Pharmaceutical Industries Limited Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Monkeypox Treatment Market Size United States VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. Monkeypox Treatment Market Trends
Table 3. Monkeypox Treatment Market Drivers
Table 4. Monkeypox Treatment Market Challenges
Table 5. Monkeypox Treatment Market Restraints
Table 6. Global Monkeypox Treatment Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. United States Monkeypox Treatment Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Monkeypox Treatment Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. United States Monkeypox Treatment Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of Monkeypox Treatment, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Monkeypox Treatment Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Monkeypox Treatment Revenue Share by Player, 2018-2023
Table 13. Global Monkeypox Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Monkeypox Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Treatment as of 2022)
Table 15. Global Key Players of Monkeypox Treatment, Headquarters and Area Served
Table 16. Global Key Players of Monkeypox Treatment, Product and Application
Table 17. Global Key Players of Monkeypox Treatment, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Monkeypox Treatment in United States, Ranked by Revenue (2022) & (US$ Million)
Table 20. United States Monkeypox Treatment Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. United States Monkeypox Treatment Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Monkeypox Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global Monkeypox Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Monkeypox Treatment Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Monkeypox Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Monkeypox Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Monkeypox Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Monkeypox Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Monkeypox Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas Monkeypox Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Monkeypox Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Monkeypox Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Monkeypox Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Monkeypox Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Monkeypox Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Monkeypox Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA Monkeypox Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Monkeypox Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Monkeypox Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Monkeypox Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Monkeypox Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Monkeypox Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Monkeypox Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC Monkeypox Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Monkeypox Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Monkeypox Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Monkeypox Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Monkeypox Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC Monkeypox Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Monkeypox Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 51. Bavarian Nordic Company Details
Table 52. Bavarian Nordic Business Overview
Table 53. Bavarian Nordic Monkeypox Treatment Product
Table 54. Bavarian Nordic Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 55. Bavarian Nordic Recent Development
Table 56. Chimerix, Inc. Company Details
Table 57. Chimerix, Inc. Business Overview
Table 58. Chimerix, Inc. Monkeypox Treatment Product
Table 59. Chimerix, Inc. Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 60. Chimerix, Inc. Recent Development
Table 61. CIDIC Company Limited Company Details
Table 62. CIDIC Company Limited Business Overview
Table 63. CIDIC Company Limited Monkeypox Treatment Product
Table 64. CIDIC Company Limited Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 65. CIDIC Company Limited Recent Development
Table 66. Emcure Pharmaceuticals Company Details
Table 67. Emcure Pharmaceuticals Business Overview
Table 68. Emcure Pharmaceuticals Monkeypox Treatment Product
Table 69. Emcure Pharmaceuticals Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 70. Emcure Pharmaceuticals Recent Development
Table 71. Emergent Company Details
Table 72. Emergent Business Overview
Table 73. Emergent Monkeypox Treatment Product
Table 74. Emergent Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 75. Emergent Recent Development
Table 76. Gilead Sciences Inc. Company Details
Table 77. Gilead Sciences Inc. Business Overview
Table 78. Gilead Sciences Inc. Monkeypox Treatment Product
Table 79. Gilead Sciences Inc. Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 80. Gilead Sciences Inc. Recent Development
Table 81. Hetero Drugs Limited Company Details
Table 82. Hetero Drugs Limited Business Overview
Table 83. Hetero Drugs Limited Monkeypox Treatment Product
Table 84. Hetero Drugs Limited Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 85. Hetero Drugs Limited Recent Development
Table 86. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Company Details
Table 87. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Business Overview
Table 88. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Product
Table 89. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 90. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Recent Development
Table 91. Mylan N.V. Company Details
Table 92. Mylan N.V. Business Overview
Table 93. Mylan N.V. Monkeypox Treatment Product
Table 94. Mylan N.V. Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 95. Mylan N.V. Recent Development
Table 96. Olon S.p.A. Company Details
Table 97. Olon S.p.A. Business Overview
Table 98. Olon S.p.A. Monkeypox Treatment Product
Table 99. Olon S.p.A. Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 100. Olon S.p.A. Recent Development
Table 101. Piramal Pharma Solutions Company Details
Table 102. Piramal Pharma Solutions Business Overview
Table 103. Piramal Pharma Solutions Monkeypox Treatment Product
Table 104. Piramal Pharma Solutions Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 105. Piramal Pharma Solutions Recent Development
Table 106. SIGA Technologies Inc. Company Details
Table 107. SIGA Technologies Inc. Business Overview
Table 108. SIGA Technologies Inc. Monkeypox Treatment Product
Table 109. SIGA Technologies Inc. Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 110. SIGA Technologies Inc. Recent Development
Table 111. Sonofi SA Company Details
Table 112. Sonofi SA Business Overview
Table 113. Sonofi SA Monkeypox Treatment Product
Table 114. Sonofi SA Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 115. Sonofi SA Recent Development
Table 116. Teva Pharmaceutical Industries Limited Company Details
Table 117. Teva Pharmaceutical Industries Limited Business Overview
Table 118. Teva Pharmaceutical Industries Limited Monkeypox Treatment Product
Table 119. Teva Pharmaceutical Industries Limited Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 120. Teva Pharmaceutical Industries Limited Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Monkeypox Treatment Product Picture
Figure 2. Global Monkeypox Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Monkeypox Treatment Market Size 2018-2033 (US$ Million)
Figure 4. United States Monkeypox Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. United States Monkeypox Treatment Market Size 2018-2033 (US$ Million)
Figure 6. United States Monkeypox Treatment Market Share in Global 2018-2033
Figure 7. Monkeypox Treatment Report Years Considered
Figure 8. Product Picture of Oral
Figure 9. Product Picture of Injectable
Figure 10. Global Monkeypox Treatment Market Share by Type in 2022 & 2033
Figure 11. Global Monkeypox Treatment Market Size by Type (2018-2033) & (US$ Million)
Figure 12. Global Monkeypox Treatment Market Share by Type (2018-2033)
Figure 13. United States Monkeypox Treatment Market Share by Type in 2022 & 2033
Figure 14. United States Monkeypox Treatment Market Size by Type (2018-2033) & (US$ Million)
Figure 15. United States Monkeypox Treatment Market Share by Type (2018-2033)
Figure 16. Product Picture of Hospital Pharmacy
Figure 17. Product Picture of Online Pharmacy
Figure 18. Product Picture of Retail Pharmacy
Figure 19. Global Monkeypox Treatment Market Share by Application in 2022 & 2033
Figure 20. Global Monkeypox Treatment Market Size by Application (2018-2033) & (US$ Million)
Figure 21. Global Monkeypox Treatment Market Share by Application (2018-2033)
Figure 22. United States Monkeypox Treatment Market Share by Application in 2022 & 2033
Figure 23. United States Monkeypox Treatment Market Size by Application (2018-2033) & (US$ Million)
Figure 24. United States Monkeypox Treatment Market Share by Application (2018-2033)
Figure 25. The Top 5 and 10 Largest Companies of Monkeypox Treatment in the World: Market Share by Monkeypox Treatment Revenue in 2022
Figure 26. Global Monkeypox Treatment Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 27. Global Monkeypox Treatment Market Share by Region (2018-2033)
Figure 28. Americas Monkeypox Treatment Market Size Growth Rate 2018-2033 (US$ Million)
Figure 29. Americas Monkeypox Treatment Market Share by Type (2018-2033)
Figure 30. Americas Monkeypox Treatment Market Share by Application (2018-2033)
Figure 31. United States Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 32. Canada Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 33. Mexico Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Brazil Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. EMEA Monkeypox Treatment Market Size Growth Rate 2018-2033 (US$ Million)
Figure 36. EMEA Monkeypox Treatment Market Share by Type (2018-2033)
Figure 37. EMEA Monkeypox Treatment Market Share by Application (2018-2033)
Figure 38. Europe Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 39. Middle East Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. Africa Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. China Monkeypox Treatment Market Size Growth Rate 2018-2033 (US$ Million)
Figure 42. China Monkeypox Treatment Market Share by Type (2018-2033)
Figure 43. China Monkeypox Treatment Market Share by Application (2018-2033)
Figure 44. APAC Monkeypox Treatment Market Size Growth Rate 2018-2033 (US$ Million)
Figure 45. APAC Monkeypox Treatment Market Share by Type (2018-2033)
Figure 46. APAC Monkeypox Treatment Market Share by Application (2018-2033)
Figure 47. Japan Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 48. South Korea Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 49. China Taiwan Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. India Monkeypox Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. Bavarian Nordic Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 53. Chimerix, Inc. Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 54. CIDIC Company Limited Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 55. Emcure Pharmaceuticals Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 56. Emergent Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 57. Gilead Sciences Inc. Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 58. Hetero Drugs Limited Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 59. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 60. Mylan N.V. Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 61. Olon S.p.A. Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 62. Piramal Pharma Solutions Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 63. SIGA Technologies Inc. Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 64. Sonofi SA Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 65. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed